BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. 2017;8:20741-20750. [PMID: 28186964 DOI: 10.18632/oncotarget.15119] [Cited by in Crossref: 118] [Cited by in F6Publishing: 122] [Article Influence: 23.6] [Reference Citation Analysis]
Number Citing Articles
1 Jiang X, Huang Z, Sun X, Zheng X, Liu J, Shen J, Jia B, Luo H, Mai Z, Chen G, Zhao J. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. BMC Cancer 2020;20:632. [PMID: 32641093 DOI: 10.1186/s12885-020-07073-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhang F, Cui JY, Gao HF, Yu H, Gao FF, Chen JL, Chen L. Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis. Future Oncol 2020;16:2619-33. [PMID: 32804554 DOI: 10.2217/fon-2020-0095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
3 Liu H, Ni S, Wang H, Zhang Q, Weng W. Charactering tumor microenvironment reveals stromal-related transcription factors promote tumor carcinogenesis in gastric cancer. Cancer Med 2020;9:5247-57. [PMID: 32463580 DOI: 10.1002/cam4.3133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhang C, Li D, Yu R, Li C, Song Y, Chen X, Fan Y, Liu Y, Qu X. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Front Immunol 2021;12:651033. [PMID: 34054812 DOI: 10.3389/fimmu.2021.651033] [Reference Citation Analysis]
5 Aboulkheyr Es H, Zhand S, Thiery JP, Warkiani ME. Pirfenidone reduces immune-suppressive capacity of cancer-associated fibroblasts through targeting CCL17 and TNF-beta. Integr Biol (Camb) 2020;12:188-97. [PMID: 32638026 DOI: 10.1093/intbio/zyaa014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
6 Kim JW, Gautam J, Kim JE, Kim JA, Kang KW. Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor. Oncol Lett 2019;17:3981-9. [PMID: 30930994 DOI: 10.3892/ol.2019.10059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
7 Shi W, Yan D, Zhao C, Xiao M, Wang Y, Ma H, Liu T, Qin H, Zhang C, Li C, Lin J, Li S, Lv J, Lin L. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. Biochem Biophys Res Commun 2017;491:159-65. [PMID: 28711499 DOI: 10.1016/j.bbrc.2017.07.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
8 Katsube R, Noma K, Ohara T, Nishiwaki N, Kobayashi T, Komoto S, Sato H, Kashima H, Kato T, Kikuchi S, Tazawa H, Kagawa S, Shirakawa Y, Kobayashi H, Fujiwara T. Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer. Sci Rep 2021;11:1693. [PMID: 33462372 DOI: 10.1038/s41598-021-81465-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer 2019;18:70. [PMID: 30927908 DOI: 10.1186/s12943-019-0994-2] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 41.3] [Reference Citation Analysis]
10 Pang T, Yin X, Luo T, Lu Z, Nie M, Yin K, Xue X. Cancer‐associated fibroblasts promote malignancy of gastric cancer cells via Nodal signalling. Cell Biochem Funct 2020;38:4-11. [DOI: 10.1002/cbf.3446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Eichelmann A, Matuszcak C, Hummel R, Haier J. Role of miRNAs in cell signaling of cancer associated fibroblasts. The International Journal of Biochemistry & Cell Biology 2018;101:94-102. [DOI: 10.1016/j.biocel.2018.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
12 Mhaidly R, Mechta-grigoriou F. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies. Seminars in Immunology 2020;48:101417. [DOI: 10.1016/j.smim.2020.101417] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
13 Rojas A, Araya P, Gonzalez I, Morales E. Gastric Tumor Microenvironment. Adv Exp Med Biol 2020;1226:23-35. [PMID: 32030673 DOI: 10.1007/978-3-030-36214-0_2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
14 Yang L, Xing S, Wang K, Yi H, Du B. Paeonol attenuates aging MRC-5 cells and inhibits epithelial–mesenchymal transition of premalignant HaCaT cells induced by aging MRC-5 cell-conditioned medium. Mol Cell Biochem 2018;439:117-29. [DOI: 10.1007/s11010-017-3141-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
15 Zhong C, Tao B, Chen Y, Guo Z, Yang X, Peng L, Xia X, Chen L. B7-H3 Regulates Glioma Growth and Cell Invasion Through a JAK2/STAT3/Slug-Dependent Signaling Pathway. Onco Targets Ther 2020;13:2215-24. [PMID: 32210587 DOI: 10.2147/OTT.S237841] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
16 Zakaria MA, Rajab NF, Chua EW, Selvarajah GT, Masre SF. The Roles of Tissue Rigidity and Its Underlying Mechanisms in Promoting Tumor Growth. Cancer Invest 2020;38:445-62. [PMID: 32713210 DOI: 10.1080/07357907.2020.1802474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lee HH, Jung J, Moon A, Kang H, Cho H. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma through Suppression of IL-6 Expression. Int J Mol Sci 2019;20:E3143. [PMID: 31252615 DOI: 10.3390/ijms20133143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
18 Zheng H, Liu H, Li H, Dou W, Wang X. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Front Mol Biosci 2021;8:744677. [PMID: 34692770 DOI: 10.3389/fmolb.2021.744677] [Reference Citation Analysis]
19 Qi Y, Zhang Y, Fu X, Wang A, Yang Y, Shang Y, Gao Q. Platelet-to-lymphocyte ratio in peripheral blood: A novel independent prognostic factor in patients with melanoma. International Immunopharmacology 2018;56:143-7. [DOI: 10.1016/j.intimp.2018.01.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
20 Jin Z, Lu Y, Wu X, Pan T, Yu Z, Hou J, Wu A, Li J, Yang Z, Li C, Yan M, Yan C, Zhu Z, Liu B, Qiu W, Su L. The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer. Redox Biol 2021;46:102076. [PMID: 34315112 DOI: 10.1016/j.redox.2021.102076] [Reference Citation Analysis]
21 Li X, Song Q, Guo X, Wang L, Zhang Q, Cao L, Ren Y, Wu X, Meng Z, Xu K. The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8. Onco Targets Ther 2020;13:2711-23. [PMID: 32280245 DOI: 10.2147/OTT.S246235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Wu CJ, Sundararajan V, Sheu BC, Huang RY, Wei LH. Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity. Cancers (Basel) 2019;12:E24. [PMID: 31861720 DOI: 10.3390/cancers12010024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
23 Zhai Q, Li H, Sun L, Yuan Y, Wang X. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis. Breast Cancer 2019;26:784-91. [DOI: 10.1007/s12282-019-00988-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Polak KL, Chernosky NM, Smigiel JM, Tamagno I, Jackson MW. Balancing STAT Activity as a Therapeutic Strategy. Cancers (Basel) 2019;11:E1716. [PMID: 31684144 DOI: 10.3390/cancers11111716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Brábek J, Jakubek M, Vellieux F, Novotný J, Kolář M, Lacina L, Szabo P, Strnadová K, Rösel D, Dvořánková B, Smetana K Jr. Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19. Int J Mol Sci 2020;21:E7937. [PMID: 33114676 DOI: 10.3390/ijms21217937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
27 Hernandez-Vargas H, Goldsmith C, Mathot P, Dante R. Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers. Epigenetics 2020;15:511-23. [PMID: 31838945 DOI: 10.1080/15592294.2019.1699893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, Ghasemi Chaleshtari M, Edalati Fathabad M, Baghaei M, Haghnavaz N, Baradaran B, Hojjat-Farsangi M, Ghalamfarsa G, Sabz G, Hasanzadeh S, Jadidi-Niaragh F. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020;149:487-500. [PMID: 32004600 DOI: 10.1016/j.ijbiomac.2020.01.273] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
29 Jiang B, Shi W, Li P, Wu Y, Li Y, Bao C. The mechanism of and the association between interleukin-27 and chemotherapeutic drug sensitivity in lung cancer. Oncol Lett 2021;21:14. [PMID: 33240420 DOI: 10.3892/ol.2020.12275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Wang Y, Chu Y, Ren X, Xiang H, Xi Y, Ma X, Zhu K, Guo Z, Zhou C, Zhang G, Chen B. Epidural adipose tissue-derived mesenchymal stem cell activation induced by lung cancer cells promotes malignancy and EMT of lung cancer. Stem Cell Res Ther 2019;10:168. [PMID: 31196220 DOI: 10.1186/s13287-019-1280-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
31 Aziz MAAE, Agarwal K, Dasari S, Mitra AAK. Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis. Cancers (Basel) 2019;11:E1608. [PMID: 31640297 DOI: 10.3390/cancers11101608] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
32 Ba P, Xu M, Yu M, Li L, Duan X, Lv S, Fu G, Yang J, Yang P, Yang C, Sun Q. Curcumin suppresses the proliferation and tumorigenicity of Cal27 by modulating cancer‐associated fibroblasts of TSCC. Oral Dis 2020;26:1375-83. [DOI: 10.1111/odi.13306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
33 Linares J, Marín-Jiménez JA, Badia-Ramentol J, Calon A. Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy. Front Cell Dev Biol 2020;8:621070. [PMID: 33553157 DOI: 10.3389/fcell.2020.621070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
34 Asif PJ, Longobardi C, Hahne M, Medema JP. The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis. Cancers (Basel) 2021;13:4720. [PMID: 34572947 DOI: 10.3390/cancers13184720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 You J, Li M, Tan Y, Cao L, Gu Q, Yang H, Hu C. Snail1-expressing cancer-associated fibroblasts induce lung cancer cell epithelial-mesenchymal transition through miR-33b. Oncotarget. 2017;8:114769-114786. [PMID: 29383119 DOI: 10.18632/oncotarget.23082] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
36 Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K. Fibroblasts in the Tumor Microenvironment: Shield or Spear? Int J Mol Sci 2018;19:E1532. [PMID: 29883428 DOI: 10.3390/ijms19051532] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 22.0] [Reference Citation Analysis]
37 Olea-Flores M, Juárez-Cruz JC, Zuñiga-Eulogio MD, Acosta E, García-Rodríguez E, Zacapala-Gomez AE, Mendoza-Catalán MA, Ortiz-Ortiz J, Ortuño-Pineda C, Navarro-Tito N. New Actors Driving the Epithelial-Mesenchymal Transition in Cancer: The Role of Leptin. Biomolecules 2020;10:E1676. [PMID: 33334030 DOI: 10.3390/biom10121676] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bae CA, Ham IH, Oh HJ, Lee D, Woo J, Son SY, Yoon JH, Lorens JB, Brekken RA, Kim TM, Han SU, Park WS, Hur H. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma. Gastric Cancer 2020;23:824-36. [PMID: 32239298 DOI: 10.1007/s10120-020-01066-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Ham IH, Lee D, Hur H. Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments. J Oncol 2019;2019:6270784. [PMID: 31281359 DOI: 10.1155/2019/6270784] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
40 Li R, Jiang J, Shi H, Qian H, Zhang X, Xu W. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci 2020;77:1661-80. [PMID: 31659415 DOI: 10.1007/s00018-019-03345-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 22.0] [Reference Citation Analysis]
41 Limpakan Yamada S, Wongsirisin P, Yodkeeree S, Chakrabandhu B, Chongruksut W, Limtrakul Dejkriengkraikul P. Interleukin-8 associated with chemosensitivity and poor chemotherapeutic response to gastric cancer. J Gastrointest Oncol 2019;10:1120-32. [PMID: 31949929 DOI: 10.21037/jgo.2019.09.02] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci 2021;22:5421. [PMID: 34063828 DOI: 10.3390/ijms22115421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Wang L, Zhang F, Cui JY, Chen L, Chen YT, Liu BW. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway. Oncol Rep 2018;39:2081-90. [PMID: 29565447 DOI: 10.3892/or.2018.6311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
44 Singh S, Tran S, Putman J, Tavana H. Three-dimensional models of breast cancer-fibroblasts interactions. Exp Biol Med (Maywood) 2020;245:879-88. [PMID: 32276543 DOI: 10.1177/1535370220917366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Cai H, Zhang Y, Meng F, Cui C, Li H, Sui M, Zhang H, Lu S. Preoperative Serum IL6, IL8, and TNF-α May Predict the Recurrence of Hepatocellular Cancer. Gastroenterol Res Pract 2019;2019:6160783. [PMID: 31781194 DOI: 10.1155/2019/6160783] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Koustoulidou S, Hoorens MWH, Dalm SU, Mahajan S, Debets R, Seimbille Y, de Jong M. Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy. Cancers (Basel) 2021;13:1100. [PMID: 33806468 DOI: 10.3390/cancers13051100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
47 Chandra R, Balachandar N, Wang S, Reznik S, Zeh H, Porembka M. The changing face of gastric cancer: epidemiologic trends and advances in novel therapies. Cancer Gene Ther 2021;28:390-9. [PMID: 33009508 DOI: 10.1038/s41417-020-00234-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Yang L, Zhang R, Yang J, Bi T, Zhou S. FKBP14 Promotes The Proliferation And Migration Of Colon Carcinoma Cells Through Targeting IL-6/STAT3 Signaling Pathway. Onco Targets Ther 2019;12:9069-76. [PMID: 31802914 DOI: 10.2147/OTT.S222555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
49 Li S, Cong X, Gao H, Lan X, Li Z, Wang W, Song S, Wang Y, Li C, Zhang H, Zhao Y, Xue Y. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res 2019;38:6. [PMID: 30616627 DOI: 10.1186/s13046-018-1003-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
50 Yu X, Hu L, Li S, Shen J, Wang D, Xu R, Yang H. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p. Cell Death Dis 2019;10:280. [PMID: 30911001 DOI: 10.1038/s41419-019-1509-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]
51 Attia YM, Tawfiq RA, Gibriel AA, Ali AA, Kassem DH, Hammam OA, Elmazar MM. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model. Biochem Pharmacol 2021;186:114497. [PMID: 33675775 DOI: 10.1016/j.bcp.2021.114497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Meng Q, Luo X, Chen J, Wang D, Chen E, Zhang W, Zhang G, Zhou W, Xu J, Song Z. Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020;1874:188443. [DOI: 10.1016/j.bbcan.2020.188443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, Deng S, Zhou H. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther 2021;6:218. [PMID: 34108441 DOI: 10.1038/s41392-021-00641-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Fernando K, Kwang LG, Lim JTC, Fong ELS. Hydrogels to engineer tumor microenvironments in vitro. Biomater Sci 2021;9:2362-83. [DOI: 10.1039/d0bm01943g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
55 Harmer D, Falank C, Reagan MR. Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma.Front Endocrinol (Lausanne). 2018;9:788. [PMID: 30671025 DOI: 10.3389/fendo.2018.00788] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
56 Wang H, Li H, Jiang Q, Dong X, Li S, Cheng S, Shi J, Liu L, Qian Z, Dong J. HOTAIRM1 Promotes Malignant Progression of Transformed Fibroblasts in Glioma Stem-Like Cells Remodeled Microenvironment via Regulating miR-133b-3p/TGFβ Axis. Front Oncol 2021;11:603128. [PMID: 33816233 DOI: 10.3389/fonc.2021.603128] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Lu Y, Xin D, Guan L, Xu M, Yang Y, Chen Y, Yang Y, Wang-Gillam A, Wang L, Zong S, Wang F. Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway. Front Oncol 2021;11:762523. [PMID: 34881181 DOI: 10.3389/fonc.2021.762523] [Reference Citation Analysis]
58 Tao Y, Yang S, Wu Y, Fang X, Wang Y, Song Y, Han T. MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process. Oncotarget 2017;8:88870-81. [PMID: 29179483 DOI: 10.18632/oncotarget.21488] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
59 Foster DS, Jones RE, Ransom RC, Longaker MT, Norton JA. The evolving relationship of wound healing and tumor stroma. JCI Insight 2018;3:99911. [PMID: 30232274 DOI: 10.1172/jci.insight.99911] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 14.3] [Reference Citation Analysis]
60 Cheng Q, Li X, Liu J, Ye Q, Chen Y, Tan S, Liu J. Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a. Stem Cells Int 2017;2017:9012152. [PMID: 29333170 DOI: 10.1155/2017/9012152] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
61 Angelucci C, D'Alessio A, Iacopino F, Proietti G, Di Leone A, Masetti R, Sica G. Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5. Oncotarget 2018;9:24364-80. [PMID: 29849946 DOI: 10.18632/oncotarget.25273] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
62 Montero P, Milara J, Roger I, Cortijo J. Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. Int J Mol Sci 2021;22:6211. [PMID: 34207510 DOI: 10.3390/ijms22126211] [Reference Citation Analysis]
63 Kim HS, Kim MG, Min KW, Jung US, Kim DH. High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer. PLoS One 2021;16:e0252052. [PMID: 34038440 DOI: 10.1371/journal.pone.0252052] [Reference Citation Analysis]
64 Xu C, Li X, Guo P, Wang J. Hypoxia-Induced Activation of JAK/STAT3 Signaling Pathway Promotes Trophoblast Cell Viability and Angiogenesis in Preeclampsia. Med Sci Monit 2017;23:4909-17. [PMID: 29030540 DOI: 10.12659/msm.905418] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
65 Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance. Cancers (Basel) 2021;13:4363. [PMID: 34503172 DOI: 10.3390/cancers13174363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Zhang YJ, Min Q, Huang Y, Liu HD, Zhu ZY, Jiang FJ, Hua HQ. Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer. Evid Based Complement Alternat Med 2020;2020:8274021. [PMID: 33144870 DOI: 10.1155/2020/8274021] [Reference Citation Analysis]
67 Sebastian A, Hum NR, Martin KA, Gilmore SF, Peran I, Byers SW, Wheeler EK, Coleman MA, Loots GG. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer. Cancers (Basel) 2020;12:E1307. [PMID: 32455670 DOI: 10.3390/cancers12051307] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
68 Bi H, Zhang Z, Guo L, Fu C. Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status. Oncotarget 2017;8:63258-64. [PMID: 28968986 DOI: 10.18632/oncotarget.18791] [Reference Citation Analysis]
69 Tang Y, Tong X, Li Y, Jiang G, Yu M, Chen Y, Dong S. JAK2/STAT3 pathway is involved in the protective effects of epidermal growth factor receptor activation against cerebral ischemia/reperfusion injury in rats. Neurosci Lett. 2018;662:219-226. [PMID: 29061394 DOI: 10.1016/j.neulet.2017.10.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
70 Quan J, Dong D, Lun Y, Sun B, Sun H, Wang Q, Yuan G. Circular RNA circHIAT1 inhibits proliferation and epithelial-mesenchymal transition of gastric cancer cell lines through downregulation of miR-21. J Biochem Mol Toxicol 2020;34:e22458. [PMID: 32020707 DOI: 10.1002/jbt.22458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
71 Sun Y, Wang R, Qiao M, Xu Y, Guan W, Wang L. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers. J Cell Physiol 2018;233:6359-69. [PMID: 29334123 DOI: 10.1002/jcp.26433] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
72 Wang L, Saci A, Szabo PM, Chasalow SD, Castillo-Martin M, Domingo-Domenech J, Siefker-Radtke A, Sharma P, Sfakianos JP, Gong Y, Dominguez-Andres A, Oh WK, Mulholland D, Azrilevich A, Hu L, Cordon-Cardo C, Salmon H, Bhardwaj N, Zhu J, Galsky MD. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nat Commun 2018;9:3503. [PMID: 30158554 DOI: 10.1038/s41467-018-05992-x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 100] [Article Influence: 21.3] [Reference Citation Analysis]
73 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
74 Jang I, Beningo KA. Integrins, CAFs and Mechanical Forces in the Progression of Cancer. Cancers (Basel) 2019;11:E721. [PMID: 31137693 DOI: 10.3390/cancers11050721] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 15.7] [Reference Citation Analysis]
75 Oya Y, Hayakawa Y, Koike K. Tumor microenvironment in gastric cancers. Cancer Sci 2020;111:2696-707. [PMID: 32519436 DOI: 10.1111/cas.14521] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
76 Ashrafizadeh M, Zarrabi A, Orouei S, Zarrin V, Rahmani Moghadam E, Zabolian A, Mohammadi S, Hushmandi K, Gharehaghajlou Y, Makvandi P, Najafi M, Mohammadinejad R. STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects. Biology (Basel) 2020;9:E126. [PMID: 32545648 DOI: 10.3390/biology9060126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
77 Zhou Q, Wu X, Wang X, Yu Z, Pan T, Li Z, Chang X, Jin Z, Li J, Zhu Z, Liu B, Su L. The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene 2020;39:1414-28. [PMID: 31659258 DOI: 10.1038/s41388-019-1078-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
78 Guo X, Shen X, Yong Z. MiR-101 Protects Against the Cerebral I/R Injury Through Regulating JAK2/STAT3 Signaling Pathway. Neuropsychiatr Dis Treat 2021;17:2791-802. [PMID: 34465995 DOI: 10.2147/NDT.S292471] [Reference Citation Analysis]
79 Shimizu D, Kanda M, Kodera Y. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer. World J Gastrointest Oncol 2018; 10(6): 124-136 [PMID: 29988904 DOI: 10.4251/wjgo.v10.i6.124] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
80 Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA, Alvarez-Sánchez ME. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Front Oncol 2019;9:1370. [PMID: 31921634 DOI: 10.3389/fonc.2019.01370] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 41.7] [Reference Citation Analysis]
81 Ray S, Coulter DW, Gray SD, Sughroue JA, Roychoudhury S, McIntyre EM, Chaturvedi NK, Bhakat KK, Joshi SS, McGuire TR, Sharp JG. Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21. Mol Carcinog 2018;57:536-48. [PMID: 29280516 DOI: 10.1002/mc.22778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
82 Kersy O, Loewenstein S, Lubezky N, Sher O, Simon NB, Klausner JM, Lahat G. Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases. Front Oncol 2019;9:1267. [PMID: 31803630 DOI: 10.3389/fonc.2019.01267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
83 Piper M, Mueller AC, Karam SD. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy. Mol Carcinog 2020;59:754-65. [PMID: 32363633 DOI: 10.1002/mc.23205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
84 Carvalho LS, Gonçalves N, Fonseca NA, Moreira JN. Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis. Pharmaceuticals (Basel) 2021;14:60. [PMID: 33451077 DOI: 10.3390/ph14010060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
85 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Reference Citation Analysis]
86 Baj J, Korona-Głowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells 2020;9:E1055. [PMID: 32340207 DOI: 10.3390/cells9041055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
87 Sanford-Crane H, Abrego J, Sherman MH. Fibroblasts as Modulators of Local and Systemic Cancer Metabolism. Cancers (Basel) 2019;11:E619. [PMID: 31058816 DOI: 10.3390/cancers11050619] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
88 Liu L, Song Z, Zhao Y, Li C, Wei H, Ma J, Du Y. HAVCR1 expression might be a novel prognostic factor for gastric cancer. PLoS One 2018;13:e0206423. [PMID: 30388143 DOI: 10.1371/journal.pone.0206423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 He C, Hua W, Liu J, Fan L, Wang H, Sun G. Exosomes derived from endoplasmic reticulum-stressed liver cancer cells enhance the expression of cytokines in macrophages via the STAT3 signaling pathway. Oncol Lett 2020;20:589-600. [PMID: 32565984 DOI: 10.3892/ol.2020.11609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
90 Hanley CJ, Thomas GJ. Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives. Oncotarget 2021;12:1427-33. [PMID: 34262652 DOI: 10.18632/oncotarget.27936] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
91 Li Y, Wang R, Xiong S, Wang X, Zhao Z, Bai S, Wang Y, Zhao Y, Cheng B. Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling. J Mol Med (Berl) 2019;97:243-55. [PMID: 30564864 DOI: 10.1007/s00109-018-1731-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
92 Kwa MQ, Herum KM, Brakebusch C. Cancer-associated fibroblasts: how do they contribute to metastasis? Clin Exp Metastasis 2019;36:71-86. [PMID: 30847799 DOI: 10.1007/s10585-019-09959-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
93 Jiang YN, Ni XY, Yan HQ, Shi L, Lu NN, Wang YN, Li Q, Gao FG. Interleukin 6-triggered ataxia-telangiectasia mutated kinase activation facilitates epithelial-to-mesenchymal transition in lung cancer by upregulating vimentin expression. Exp Cell Res 2019;381:165-71. [PMID: 31100307 DOI: 10.1016/j.yexcr.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Zhuang M, Ding X, Song W, Chen H, Guan H, Yu Y, Zhang Z, Dong X. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients. Aging (Albany NY) 2021;13:16667-83. [PMID: 34165442 DOI: 10.18632/aging.203186] [Reference Citation Analysis]
95 Cheng M, Liu P, Xu LX. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment. J Inorg Biochem 2020;210:111159. [PMID: 32652260 DOI: 10.1016/j.jinorgbio.2020.111159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
96 Shi L, Fan B, Chen D, Guo C, Xiang H, Nie Y, Zhong D, Shi X. Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through MiR-138 and MiR-34c in gastric cancer cells. Int J Clin Oncol 2020;25:1936-44. [PMID: 32959231 DOI: 10.1007/s10147-020-01749-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Li W, Ng JM, Wong CC, Ng EKW, Yu J. Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer. Oncogene. 2018;37:4903-4920. [PMID: 29795331 DOI: 10.1038/s41388-018-0341-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
98 Qin L, Cao X, Kaneko T, Voss C, Liu X, Wang G, Li SS. Dynamic interplay of two molecular switches enabled by the MEK1/2-ERK1/2 and IL-6-STAT3 signaling axes controls epithelial cell migration in response to growth factors. J Biol Chem 2021;297:101161. [PMID: 34480897 DOI: 10.1016/j.jbc.2021.101161] [Reference Citation Analysis]
99 Ren Q, Zhu P, Zhang H, Ye T, Liu D, Gong Z, Xia X. Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer. Cancer Cell Int 2020;20:92. [PMID: 32226313 DOI: 10.1186/s12935-020-01173-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
100 Goulet CR, Champagne A, Bernard G, Vandal D, Chabaud S, Pouliot F, Bolduc S. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. BMC Cancer. 2019;19:137. [PMID: 30744595 DOI: 10.1186/s12885-019-5353-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 21.3] [Reference Citation Analysis]
101 Zhu M, Yang M, Yang Q, Liu W, Geng H, Pan L, Wang L, Ge R, Ji L, Cui S, Li Z. Chronic Hypoxia-Induced Microvessel Proliferation and Basal Membrane Degradation in the Bone Marrow of Rats Regulated through the IL-6/JAK2/STAT3/MMP-9 Pathway. Biomed Res Int 2020;2020:9204708. [PMID: 32047820 DOI: 10.1155/2020/9204708] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
102 Arshad S, Naveed M, Ullia M, Javed K, Butt A, Khawar M, Amjad F. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges. Genet Mol Biol 2020;43:e20180160. [PMID: 32167126 DOI: 10.1590/1678-4685-GMB-2018-0160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
103 Batista S, Gregório AC, Hanada Otake A, Couto N, Costa-Silva B. The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective. J Oncol 2019;2019:6240505. [PMID: 31885581 DOI: 10.1155/2019/6240505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
104 Gorczynski RM, Erin N, Maqbool T, Gorczynski CP, Gorczynski LY. Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions. Breast Cancer 2018;25:547-59. [DOI: 10.1007/s12282-018-0851-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Ferraro DA, Patella F, Zanivan S, Donato C, Aceto N, Giannotta M, Dejana E, Diepenbruck M, Christofori G, Buess M. Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells. BMC Cancer 2019;19:312. [PMID: 30947697 DOI: 10.1186/s12885-019-5521-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
106 Han XG, Mo HM, Liu XQ, Li Y, Du L, Qiao H, Fan QM, Zhao J, Zhang SH, Tang TT. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production. Front Genet 2018;9:135. [PMID: 29731768 DOI: 10.3389/fgene.2018.00135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
107 Dean T, Li NT, Cadavid JL, Ailles L, McGuigan AP. A TRACER culture invasion assay to probe the impact of cancer associated fibroblasts on head and neck squamous cell carcinoma cell invasiveness. Biomater Sci 2020;8:3078-94. [PMID: 32347842 DOI: 10.1039/c9bm02017a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Condorelli AG, Dellambra E, Logli E, Zambruno G, Castiglia D. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives. Int J Mol Sci 2019;20:E5707. [PMID: 31739489 DOI: 10.3390/ijms20225707] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
109 Li Q, Zhang D, Wang H, Xie J, Peng L, Peng Y, Zheng X, Jiang J. SLCO4A1-AS1 Facilitates the Malignant Phenotype via miR-149-5p/STAT3 Axis in Gastric Cancer Cells. J Oncol 2021;2021:1698771. [PMID: 34712324 DOI: 10.1155/2021/1698771] [Reference Citation Analysis]
110 Grauel AL, Nguyen B, Ruddy D, Laszewski T, Schwartz S, Chang J, Chen J, Piquet M, Pelletier M, Yan Z, Kirkpatrick ND, Wu J, deWeck A, Riester M, Hims M, Geyer FC, Wagner J, MacIsaac K, Deeds J, Diwanji R, Jayaraman P, Yu Y, Simmons Q, Weng S, Raza A, Minie B, Dostalek M, Chikkegowda P, Ruda V, Iartchouk O, Chen N, Thierry R, Zhou J, Pruteanu-Malinici I, Fabre C, Engelman JA, Dranoff G, Cremasco V. TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts. Nat Commun 2020;11:6315. [PMID: 33298926 DOI: 10.1038/s41467-020-19920-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
111 Liu H, Liu Y, Zhang X, Wang X. Current Study of RhoA and Associated Signaling Pathways in Gastric Cancer.Curr Stem Cell Res Ther. 2020;15:607-613. [PMID: 32223738 DOI: 10.2174/1574888X15666200330143958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
112 Truffi M, Sorrentino L, Corsi F. Fibroblasts in the Tumor Microenvironment. Adv Exp Med Biol 2020;1234:15-29. [PMID: 32040852 DOI: 10.1007/978-3-030-37184-5_2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
113 Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, He Y, Yuan Y. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res 2020;39:9. [PMID: 31928530 DOI: 10.1186/s13046-019-1514-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
114 Marques P, Grossman AB, Korbonits M. The tumour microenvironment of pituitary neuroendocrine tumours. Front Neuroendocrinol 2020;58:100852. [PMID: 32553750 DOI: 10.1016/j.yfrne.2020.100852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
115 Seeneevassen L, Bessède E, Mégraud F, Lehours P, Dubus P, Varon C. Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies. Int J Mol Sci 2021;22:3418. [PMID: 33810350 DOI: 10.3390/ijms22073418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
116 Sexton RE, Al Hallak MN, Diab M, Azmi AS. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev 2020;39:1179-203. [PMID: 32894370 DOI: 10.1007/s10555-020-09925-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
117 Yin J, Guo Y, Li Z. Platelet-derived growth factor-B signalling might promote epithelial-mesenchymal transition in gastric carcinoma cells through activation of the MAPK/ERK pathway. Contemp Oncol (Pozn) 2021;25:1-6. [PMID: 33911974 DOI: 10.5114/wo.2021.103938] [Reference Citation Analysis]
118 Ham IH, Oh HJ, Jin H, Bae CA, Jeon SM, Choi KS, Son SY, Han SU, Brekken RA, Lee D, Hur H. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer. 2019;18:68. [PMID: 30927911 DOI: 10.1186/s12943-019-0972-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
119 Ganguly D, Chandra R, Karalis J, Teke M, Aguilera T, Maddipati R, Wachsmann MB, Ghersi D, Siravegna G, Zeh HJ 3rd, Brekken R, Ting DT, Ligorio M. Cancer-Associated Fibroblasts: Versatile Players in the Tumor Microenvironment. Cancers (Basel) 2020;12:E2652. [PMID: 32957515 DOI: 10.3390/cancers12092652] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
120 Xu M, Ren L, Fan J, Huang L, Zhou L, Li X, Ye X. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. Life Sci 2021;290:120266. [PMID: 34968467 DOI: 10.1016/j.lfs.2021.120266] [Reference Citation Analysis]
121 Wang YC, Dai Y, Xu GL, Yu W, Quan RL, Zhao YJ. Association Between EphA1 and Tumor Microenvironment in Gastric Carcinoma and its Clinical Significance. Med Sci Monit 2020;26:e923409. [PMID: 32218416 DOI: 10.12659/MSM.923409] [Reference Citation Analysis]
122 Sakamoto S, Kagawa S, Kuwada K, Ito A, Kajioka H, Kakiuchi Y, Watanabe M, Kagawa T, Yoshida R, Kikuchi S, Kuroda S, Tazawa H, Fujiwara T. Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer. Oncoimmunology 2019;8:e1671760. [PMID: 31741772 DOI: 10.1080/2162402X.2019.1671760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
123 Gyamfi J, Lee YH, Eom M, Choi J. Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells. Sci Rep 2018;8:8859. [PMID: 29891854 DOI: 10.1038/s41598-018-27184-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
124 Santos MP, Pereira JN, Delabio RW, Smith MAC, Payão SLM, Carneiro LC, Barbosa MS, Rasmussen LT. Increased expression of interleukin-6 gene in gastritis and gastric cancer. Braz J Med Biol Res 2021;54:e10687. [PMID: 34008757 DOI: 10.1590/1414-431X2020e10687] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Meng H, Pang Y, Liu G, Luo Z, Tan H, Liu X. Podocarpusflavone A inhibits cell growth of skin cutaneous melanoma by suppressing STAT3 signaling. J Dermatol Sci 2020;100:201-8. [PMID: 33127205 DOI: 10.1016/j.jdermsci.2020.10.008] [Reference Citation Analysis]
126 Fujisawa Y, Matsuda K, Uehara T. Osteopontin enhances the migration of lung fibroblasts via upregulation of interleukin-6 through the extracellular signal-regulated kinase (ERK) pathway. Biol Chem 2020;401:1071-80. [PMID: 32924371 DOI: 10.1515/hsz-2020-0125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]